HK1161686A1 - Use of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h- pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels 7--nn5--4--3--35--4h-[45-b]-1- - Google Patents
Use of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h- pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels 7--nn5--4--3--35--4h-[45-b]-1-Info
- Publication number
- HK1161686A1 HK1161686A1 HK12102251.6A HK12102251A HK1161686A1 HK 1161686 A1 HK1161686 A1 HK 1161686A1 HK 12102251 A HK12102251 A HK 12102251A HK 1161686 A1 HK1161686 A1 HK 1161686A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridazino
- biomarker
- acetamide
- indole
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08291013A EP2181717A1 (en) | 2008-10-28 | 2008-10-28 | Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
PCT/IB2009/007562 WO2010049819A1 (en) | 2008-10-28 | 2009-10-27 | Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1161686A1 true HK1161686A1 (en) | 2012-08-03 |
Family
ID=40262247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12102251.6A HK1161686A1 (en) | 2008-10-28 | 2012-03-06 | Use of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h- pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels 7--nn5--4--3--35--4h-[45-b]-1- |
Country Status (32)
Country | Link |
---|---|
US (2) | US20120039816A1 (es) |
EP (2) | EP2181717A1 (es) |
JP (1) | JP5743894B2 (es) |
KR (2) | KR20160070846A (es) |
CN (1) | CN102223899B (es) |
AR (1) | AR073983A1 (es) |
AU (1) | AU2009309339C1 (es) |
BR (1) | BRPI0920412A2 (es) |
CA (1) | CA2741620C (es) |
CL (2) | CL2011000954A1 (es) |
CO (1) | CO6382141A2 (es) |
CY (1) | CY1115211T1 (es) |
DK (1) | DK2349352T3 (es) |
EA (1) | EA020612B1 (es) |
ES (1) | ES2452665T3 (es) |
HK (1) | HK1161686A1 (es) |
HR (1) | HRP20140250T1 (es) |
IL (1) | IL212473A (es) |
MA (1) | MA32803B1 (es) |
ME (2) | ME01128B (es) |
MX (1) | MX2011004420A (es) |
MY (1) | MY152968A (es) |
NZ (1) | NZ592479A (es) |
PL (1) | PL2349352T3 (es) |
PT (1) | PT2349352E (es) |
RS (1) | RS53273B (es) |
SI (1) | SI2349352T1 (es) |
SM (1) | SMT201400070B (es) |
TW (1) | TWI450728B (es) |
UY (1) | UY32206A (es) |
WO (1) | WO2010049819A1 (es) |
ZA (1) | ZA201103082B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201016038D0 (en) * | 2010-09-24 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method |
GB201016411D0 (en) * | 2010-09-30 | 2010-11-10 | Ge Healthcare Ltd | In vivo imaging method for cancer |
CA3208480A1 (en) * | 2021-01-15 | 2022-07-21 | Minnetronix Neuro, Inc. | Systems and methods for managing, monitoring, and treating patient conditions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2766823B1 (fr) | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
FR2788696B1 (fr) | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
JP4362457B2 (ja) * | 2005-04-26 | 2009-11-11 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
EP2752415B8 (en) * | 2006-08-24 | 2017-11-15 | Australian Nuclear Science & Technology Organisation | Fluorinated ligands for targeting peripheral benzodiazepine receptors |
US20100055036A1 (en) * | 2007-03-12 | 2010-03-04 | National Institute of Radiolotgical Sciences | Pet visualization of amyloid-associated neuroinflammation in the brain |
EP1997515A1 (en) * | 2007-05-30 | 2008-12-03 | Bayer Schering Pharma Aktiengesellschaft | Use of radiolabelled phenyloxyaniline derivatives for imaging diseases associated with peripheral benzodiazepin receptor's activation |
-
2008
- 2008-10-28 EP EP08291013A patent/EP2181717A1/en not_active Withdrawn
-
2009
- 2009-10-27 PT PT97605935T patent/PT2349352E/pt unknown
- 2009-10-27 NZ NZ592479A patent/NZ592479A/xx not_active IP Right Cessation
- 2009-10-27 CN CN200980143233.4A patent/CN102223899B/zh not_active Expired - Fee Related
- 2009-10-27 MX MX2011004420A patent/MX2011004420A/es active IP Right Grant
- 2009-10-27 US US13/126,648 patent/US20120039816A1/en not_active Abandoned
- 2009-10-27 JP JP2011533855A patent/JP5743894B2/ja not_active Expired - Fee Related
- 2009-10-27 AR ARP090104122A patent/AR073983A1/es unknown
- 2009-10-27 EP EP09760593.5A patent/EP2349352B1/en active Active
- 2009-10-27 ME MEP-2011-72A patent/ME01128B/me unknown
- 2009-10-27 KR KR1020167015060A patent/KR20160070846A/ko not_active Application Discontinuation
- 2009-10-27 RS RS20140138A patent/RS53273B/en unknown
- 2009-10-27 MY MYPI20111854 patent/MY152968A/en unknown
- 2009-10-27 ES ES09760593.5T patent/ES2452665T3/es active Active
- 2009-10-27 SI SI200930891T patent/SI2349352T1/sl unknown
- 2009-10-27 EA EA201170613A patent/EA020612B1/ru not_active IP Right Cessation
- 2009-10-27 BR BRPI0920412A patent/BRPI0920412A2/pt not_active Application Discontinuation
- 2009-10-27 PL PL09760593T patent/PL2349352T3/pl unknown
- 2009-10-27 KR KR1020117009627A patent/KR20110098711A/ko not_active Application Discontinuation
- 2009-10-27 ME MEP-2014-31A patent/ME01819B/me unknown
- 2009-10-27 DK DK09760593.5T patent/DK2349352T3/da active
- 2009-10-27 WO PCT/IB2009/007562 patent/WO2010049819A1/en active Application Filing
- 2009-10-27 CA CA2741620A patent/CA2741620C/en not_active Expired - Fee Related
- 2009-10-27 AU AU2009309339A patent/AU2009309339C1/en not_active Ceased
- 2009-10-28 TW TW098136524A patent/TWI450728B/zh not_active IP Right Cessation
- 2009-10-28 UY UY0001032206A patent/UY32206A/es not_active Application Discontinuation
-
2011
- 2011-04-26 ZA ZA2011/03082A patent/ZA201103082B/en unknown
- 2011-04-26 IL IL212473A patent/IL212473A/en not_active IP Right Cessation
- 2011-04-27 CO CO11051319A patent/CO6382141A2/es active IP Right Grant
- 2011-04-28 CL CL2011000954A patent/CL2011000954A1/es unknown
- 2011-05-19 MA MA33858A patent/MA32803B1/fr unknown
-
2012
- 2012-03-06 HK HK12102251.6A patent/HK1161686A1/xx not_active IP Right Cessation
-
2013
- 2013-04-15 CL CL2013001041A patent/CL2013001041A1/es unknown
-
2014
- 2014-03-18 HR HRP20140250AT patent/HRP20140250T1/hr unknown
- 2014-03-24 CY CY20141100222T patent/CY1115211T1/el unknown
- 2014-06-12 SM SM201400070T patent/SMT201400070B/xx unknown
-
2016
- 2016-11-10 US US15/347,965 patent/US20170160287A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3178819T3 (en) | 5-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl-carboxamider som jak-inhibitorer | |
HK1164641A1 (en) | Azepino[4,5-b]indoles and methods of use [45-b] | |
ZA200906736B (en) | New 3-([1,2,4] Triazolo [4,3-A]Pyridin-7-YL) Benzamide derivatives | |
HK1160116A1 (en) | Pyrrolo[2,3-d]pyrimidine compounds [23-d] | |
ZA201402905B (en) | [1,2,3]triazolo [4,5-d]pyrimidine derivatives as agonist of the cannabinoid receptor 2 | |
IL211584A (en) | Macrocyclic pyrimidine compounds, their preparation and use | |
HK1151372A1 (zh) | 洗手間便利中心 | |
IL215158A0 (en) | Imidazo [2,1-b] [1,3,4] thiadiazole derivatives | |
HK1132505A1 (en) | Thiazole pyrazolopyrimidines as crf1 receptor antagonists | |
ZA201004368B (en) | Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors | |
SI2124944T1 (sl) | Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze | |
IL211030A0 (en) | Pyrazolo [5,1-b] oxazole derivatives as crf1 antagonists | |
EP2142542A4 (en) | NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704 | |
ZA201101550B (en) | 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines | |
ZA200907416B (en) | Pyrimido [4,5-D] azepine derivatives as 5-HT2C agonists | |
IL225299A0 (en) | 7-Hydroxy-pyrazolo[1,5-a]pyrimidine compounds and their use as ccr2 receptor antagonists | |
EP2259925A4 (en) | IMPROVED FLEXO CUSHIONS | |
EP2523552A4 (en) | PYRAZOLO- [1,5-A] PYRIMIDINE AS MARK HEMMER | |
SI2167470T1 (sl) | Triazolo(1,5-a)kinolini kot adenozin A3 receptorski ligandi | |
HK1161686A1 (en) | Use of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h- pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels 7--nn5--4--3--35--4h-[45-b]-1- | |
ZA201105257B (en) | 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives | |
IL206666A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
IL185640A0 (en) | Use of 2-anilino-3 ,4-dihydro-quinazolines as 5ht5a receptor antagonists | |
IL206668A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
ZA201105439B (en) | 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20181031 |